Anti-D can prevent immunization to the RhD Ag on RBCs, a phenomenon commonly termed
Ab-mediated immune suppression (AMIS). The most accepted theory to explain this effect …

Abstract Anti-D immunoglobulin (Anti-D Ig) prophylaxis prevents haemolytic disease of the
fetus and newborn. Monoclonal IgG anti-Ds (mAb-Ds) would enable unlimited supplies but …

Background Fetomaternal haemorrhage (FMH) assessment by the Kleihauer–Betke test
(KBT) is rapid but semi‐quantitative and liable to false positive results. Objectives To …

Introduction: Over the last decade the field of medicine has dramatically changed with the
introduction of biological therapies, among which monoclonal antibodies play a pivotal role …

Olovnikova et al.(“Impact on N-glycosylation profile of monoclonal anti-D antibodies as a
way to control their immunoregulatory and cytotoxic properties”(2012) Biochemistry …

The prophylaxis of the hemolytic disease of the newborn—a mandatory procedure in
obstetrics—requires significant amounts of plasma-derived polyclonal anti-D …

Results Glycosylation varied markedly among the anti-Ds. Results from the three analytical
methods determining 12 glycosylation features were similar (Tables 1–3) and concurred …

The ability of anti-D to prevent hemolytic disease of the fetus and newborn (HDFN) is an
example of antibody-mediated immune suppression (AMIS). A recombinant monoclonal …

Anti-D can prevent immunization to the RhD Ag on RBCs, a phenomenon commonly termed
Ab-mediated immune suppression (AMIS). The most accepted theory to explain this effect …

В статье Оловниковой и соавт.(Olovnikova NI, Ershler MA, Grigorieva OV, Petrov AV, and
Miterev G. Yu.«Impact on N-Glycosylation Profile of Monoclonal Anti-D Antibodies as a Way …